Skip to main content

Table 1 Patients demographics

From: Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients

 

100 μg

200 μg

No. patients enrolled

13

12

Sex

  Male

13

11

  Female

0

1

Age

  Median

69

64.5

  Range

49-72

53-79

Prior therapy

  Surgery

6

5

  Radiotherapy

11

7

  Chemotherapy

13

12

Pre-existing antibody to NY-ESO-1 antigen

3

7

No. vaccinations

  Median

8

9.5

  Range

2-27

3-21